Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium

ABSTRACT The use of a liquid biopsy to assess molecular residual disease (MRD) of solid tumors holds significant promise for improving outcomes for patients with cancer. Liquid biopsies are a minimally invasive approach for the identification of circulating tumor biomarkers through a simple blood sa...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Andrew G. Hadd, Angela Silvestro, Brittany Avin McKelvey, Jonathan Baden, Christina Bormann Chung, Ben Brown, Fernando Cruz‐Guilloty, James Godsey, Gregory Jones, Cheng‐Ho Jimmy Lin, Dorys Lopez Ramos, Daniel Norton, Melanie R. Palomares, Carol Pena, Thereasa Rich, Angel Rodriguez, Mark Stewart, Diana Merino Vega, Lauren C. Leiman
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2025-03-01
Reeks:	Clinical and Translational Science
Onderwerpen:	ctDNA liquid biopsy MRD
Online toegang:	https://doi.org/10.1111/cts.70185
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!